Resources, insights, and events focused on improving access to care, reducing disparities, and supporting inclusive innovation across the health care system. Learn more about our Health Access work.
BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, held October 18-21 in Boston. The conference recognized companies developing technologies to address a diverse…
BOSTON—AdvaMed, the Medtech Association, convened the 13th Annual Symposium on Pediatric Device Innovation on October 18 at The MedTech Conference 2026 in Boston. In collaboration with the five U.S. Food…
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, welcomed the executive order from President Trump launching a new women’s health initiative, “Advancing Women’s Health to Improve Outcomes in…
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of Leadership & Service Award, honoring his more than 45 years of leadership across…
WASHINGTON, D.C.—AdvaMed®, the Medtech Association, today announced Vincent A. “Vince” Forlenza, former chairman and CEO of BD (Becton, Dickinson and Company), as the recipient of the 2026 AdvaMed Lifetime Achievement…
Explore how gaps in female inclusion in clinical research impact health outcomes, treatment guidelines, and medical device innovation — and what leading organizations are doing about it.
For people living with disabilities and chronic conditions, access to assistive technology can make the difference between dependence and independence. In this installment of AdvaMed’s Partners in Patient Care Q&A…
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today recommended refinements the Centers for Medicare & Medicaid Services (CMS) could make to help its proposed Regulatory Alignment for Predictable and Immediate Device (RAPID)…
AUSTIN, Texas – October 8, 2026 – Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces (BCIs) to restore and enhance human capabilities, today announced that its brain-computer interface has…
Aliso Viejo, Calif. – Terumo Neuro today announced that it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing NeoCast™, an investigational next-generation…